title: Trichuris suis therapy in Crohn's disease.
abstract: BACKGROUND
  Crohn's disease is common in highly industrialised Western countries where helminths are rare and uncommon in less developed areas of the world where most people carry worms. Helminths diminish immune responsiveness in naturally colonised humans and reduce inflammation in experimental colitis. Thus exposure to helminths may help prevent or even ameliorate Crohn's disease.
  
  
  OBJECTIVE
  The aim of the study was to determine the safety and possible efficacy of the intestinal helminth Trichuris suis in the treatment of patients with active Crohn's disease.
  
  
  METHODS
  Twenty nine patients with active Crohn's disease, defined by a Crohn's disease activity index (CDAI) > or =220 were enrolled in this open label study.
  
  
  METHODS
  All patients ingested 2500 live T suis ova every three weeks for 24 weeks, and disease activity was monitored by CDAI. Remission was defined as a decrease in CDAI to less than 150 while a response was defined as a decrease in CDAI of greater than 100.
  
  
  RESULTS
  At week 24, 23 patients (79.3%) responded (decrease in CDAI >100 points or CDAI <150) and 21/29 (72.4%) remitted (CDAI <150). Mean CDAI of responders decreased 177.1 points below baseline. Analysis at week 12 yielded similar results. There were no adverse events.
  
  
  CONCLUSIONS
  This new therapy may offer a unique, safe, and efficacious alternative for Crohn's disease management. These findings also support the premise that natural exposure to helminths such as T suis affords protection from immunological diseases like Crohn's disease.
authors.affiliation: James A Clifton Center for Digestive Diseases, Department of Internal Medicine, University of Iowa Roy J and Lucille A Carver College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242, USA. robert-summers@uiowa.edu
authors.forename: R W
authors.initials: RW
authors.lastname: Summers
authors.forename: D E
authors.initials: DE
authors.lastname: Elliott
authors.forename: J F
authors.initials: JF
authors.lastname: Urban
authors.forename: R
authors.initials: R
authors.lastname: Thompson
authors.forename: J V
authors.initials: JV
authors.lastname: Weinstock
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D003424:Crohn Disease / Q000276:immunology / Q000469:parasitology / Q000628:therapy*; D005260:Female; D006790:Host-Parasite Interactions; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014257:Trichuriasis / Q000469:parasitology*; D014258:Trichuris / Q000502:physiology*